A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting.
Clinical trial NCT07399470 · COMPLETED
Trial details
- NCT number
- NCT07399470
- Sponsor
- LG Chem
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-09
- Primary completion
- 2026-02-06
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.